Clinical Trial Update: Sonodynamic Therapy With ExAblate System in Glioblastoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update shows completion of testing of sonodynamic therapy with the ExAblate system in glioblastoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED